Mango mistletoe (Dendrophthoe pentandra L. Miq) (MMDP) leaf extract which contained quercetin inhibits cancer cells. MMDP increasing effectively of 5-Fluorouracil (5-FU) as a chemotherapy agent. This study aimed to investigate the synergistic effects of MMDP combined with 5-FU to determine the percentage of apoptosis, p21, and survivin in HeLa cells. Flow cytometry analysis revealed that it increases apoptosis HeLa cell through increasing p21 and also decreased survivin percentage. The combination of 5-FU 5 µg/ml and MMDP 50 µg/ml significantly increased the percentage of p21 and apoptosis (P < 0.001; P < 0.001) and decreased survivin (P < 0.05) compared with 5-FU only group. This study indicates that the combined 5-FU and MMDP has a synergistic effect to enhance apoptosis and p21 expressions by decreasing of survivin in HeLa cells.
INTRODUCTION
Cervical cancer is the second most frequently diagnosed malignancy and one of the major causes of death in women worldwide (Tsai et al., 2012) . In 2015, it has been reported that 526 000 women suffered from cervical cancer, and 239 000 was caused by cancer deaths for women (Kashafi et al., 2017) . The occurrence of cancer is characterized by uncontrolled cell proliferation.
Human Papilloma Virus (HPV) 16 and 18 are two oncogenes responsible for 70-80% of all cervical cancer cases worldwide (Jaspers et al., 2011) . This has been proven by detection of HPV-18 expression and decreased expression of p53 in HeLa cells. Furthermore, there is evidence that p53 can induce apoptosis and cell cycle arrest can lead to cancer. P21 appears to play also a critical role in apoptosis, as this oncogene switches the p53-dependent response to DNA damage from a cancer cell. Several studies have shown that p21 induces pro-apoptotic signaling (Zang et al., 2016; Endharti et al., 2017a) .
Cancer, in general, occurs because of the inhibition of apoptosis and cell cycle arrest, which is also observed in cervical cancer. The regulation of apoptosis is influenced by p21. The promotion of the apoptosis mechanism and decrease in p21 expression results in increased apoptosis of cancer cells. The inhibition of apoptosis is regulated by various factors, one of which is the presence of the apoptosis-inhibiting protein, survivin (Jaiswal et al., 2015; Karimian et al., 2016; Endharti et al., 2017b) .
In HeLa cells, an increase in survivin mRNA expression is observed in the G2/M phase, and decreased expression of p21 results in disruption of the cell cycle, thus, inhibit apoptosis of cancer cells (Li et al., 2015) . Due to the important roles that p21 and survivin play in cancer development, they were good targets for anti-cancer treatment used to suppress the growth of cancer cells; (Hsieh et al., 2014) . p21 binding Nuclear Factor-kappaβ (NF-kβ) and Signal Transducer and Activator of Transcription (STAT) inhibit a family of antiapoptosis X-Linked Inhibitor Of Apoptosis (XIAP) including survivin occurs apoptosis (Karimian et al., 2016) .
One therapeutic agent, adjuvant 5-FU presents side-effects such as neutropenia, stomatitis, diarrhea, and cardiotoxicity (Ciccolini et al., 2010) . The active metabolites of 5-FU can inhibit the activity of thymidylate synthase (Chua et al., 2010) . Increasing the activity of 5-FU by combination treatment with natural materials is an important way to investigate for the treatment of cervical cancer. A combination treatment of 5-FU and a natural material could increase the sensitivity of cancer cells by enhancing apoptosis (Redondo-Blanco et al., 2017) .
Extracts of traditional medicines act as chemosensitizers that made cancer cells more sensitive to the effects of chemotherapeutic agents (Kong et al., 2015; Syakibaei et al., 2013; Xavier et al., 2011) . MMDP had a potential for use as an anti-cancer agent because it contained quercetin (Endharti et al., 2016) . However, the functional role of p21 in the induction of G1 cell cycle arrest and apoptosis by MMDP has not been critically addressed. Previously study has been revealed that quercetin inhibited proliferation of HeLa cells and induced apoptosis by mitochondria pathway (Merino et al., 2014) . Recently, conventional chemotherapy is combined with alternative medicines have anticancer potentials and reduce side-effects of chemotherapy (Hemaiswarya and Doble, 2013) .
Combination therapy of 5-FU and MMDP have different approaches for the discovery of novel and potential therapeutic agents, medicinal plants are still one of the best reservoirs for new therapy. However, whether these combination therapies exert antitumor activity against colon cancer is not yet clear. In this study, we presented the evidence of MMDP exhibits antitumor activities in vitro. Based on the antitumor effect of MMDP, our study examined the therapeutic potential of MMDP in inhibition of cervical cancer.
MATERIALS AND METHODS

Cell cultures and treatment
HeLa Cell Lines was cultured in complete medium Roswell Park Memorial Institute 1640 (RPMI 1640) (Gibco, USA) supplemented with 10% Fetal Bovine Serum (FBS) (Atlas Biologicals, Fort Collins, CO, USA) solution containing 100 U/ ml Penicillin and 100 U/ml Streptomycin (Gibco, USA). The cells were kept in a humidified atmosphere of 5% CO 2 at 37°C in an incubator. HeLa cells were seeded in 24-well plate (5 × 10 5 cell/ml). The cells were treated with single therapy of 5-FU or combined with a various dose of MMDP (12.5, 25 and 50 µg/ml), incubated for 24 hours.
Plant material and extraction
The mango mistletoe extract was utilized in a form of a paste. Mango mistletoe leaves were obtained from a mango farm in Probolinggo Regency, East Java, Indonesia. The mango mistletoe plant was identified and validated by a botanical biologist at the Faculty of Biology, University of Brawijaya (specimen No.0170/ Taxonomy Identification/03/2015). The extraction method was done according to Endharti et al. (2016) .
Analysis of apoptosis
Cells (1 × 10 5 ) were treated with 5-FU and MMDP after 24 hours of incubation. Following centrifugation, cells were processed for apoptosis detection using the Annexin V-FITC Apoptosis Detection Kit (e-Bioscience cat/300) as indicated by the manufacturer. Cells were incubated for 10 minutes with the Annexin V-FICT and further incubated for 5 min with propidium iodide (Sigma, Kawasaki, Japan) at 4°C. Cells were analyzed by flow cytometry using the BD FACS Calibur (Becton Dickinson, CA, USA). The percentage of apoptosis cells were quantified by Cell Quest-Pro (Becton Dickinson, USA).
Survivin and p21 analysis
The pellets were derived from cell culture, then cells were resuspended in Fixating Buffer (Biolegend, San Diego, California, USA) incubated at 4°C for 30 minutes. The pellets were incubated in Survivin Antibody (D-8) sc-17779 conjugated with FITC (Santa Cruz Biotechnology, Germany) or p21 antibody (F-5) sc-6246 mouse monoclonal conjugated with FITC (Santa Cruz Biotechnology, Germany) then were incubated for 20 minutes. Samples were immediately analyzed by flow cytometer and the data were analyzed with FACS Calibur Cell Quest-Pro (Becton Dickinson, San Jose, CA, USA).
Statistical analysis
The relative numbers of all parameters were analyzed using BD CellQuest software. All data were statistically analyzed using an independent t-test in SPSS version 18.
RESULTS AND DISCUSSION
Results
Synergistically of MMDP and 5-FU induced apoptosis
The increase of apoptosis percentage from the combined 5-FU and MMDP in different concentration (12.5, 25, 50 µg/ml) to HeLa cell was evaluated using Annexin V/propidium iodide (PI) ( Figure 1A ). This results indicated that the combined therapy significantly increases apoptosis percentage, (P < 0.001) ( Figure 1B ). Combination therapy of 5-FU and MMDP had a synergistic increase of apoptosis in HeLa cell line across the broad range of fraction affected.
The combination of MMDP and 5-FU increased p21 of HeLa cell
In this study, the percentage of p21 was observed using flow cytometry to determine the effect of 5-FU and MMDP on increasing percentage of p21 in HeLa cell. Our results showed the percentage of p21 significantly increased in almost all doses of MMDP (P < 0.001 (Figure 2A ). The percentage of p21 were significantly higher in the combination of 5-FU and MMDP 50 µg/ml than 25 μg/ml treatment. The percentage of p21 increased in a dose-dependent manner ( Figure  2B ). This finding indicates that combination of 5-FU and MMDP suppressed carcinogenesis by increasing of p21 in HeLa cells. 
MMDP reduce survivin in combination with 5-FU
In this study, survivin was decreased after treatment with 5-FU, MMDP or combination 5-FU and MMDP (Figure 3) . The result showed in the combination therapy group with a dose of extract of 50 μg/ml more decreased survivin percentage to other groups, while the untreated group showed the highest percentage of survivin. The only extracted group of 50 μg/ml showed no significant difference with the combination group of 25 μg/ml extract.
Discussion
Apoptosis occurred as a result of irreparable or incompletely repaired genomic DNA, preventing the proliferation of cells and the development of cancer, thus inducing apoptosis is one approach for the treatment of cancer in addition to conventional treatments such as radiotherapy and chemotherapy (Rebecca, 2011; Hasan et al., 2014) .
Our results showed that 5-FU enhanced apoptosis on HeLa cells when combined with MMDP. The mechanism of both 5-FU and MMDP have a different target of action to induce apoptosis in the cell cycle. 5-FU works in G1/S phase whereas MMDP in G2/M phase. Intrinsic pathway increases the permeability of membrane causing cytochrome C released from mitochondria. Our findings consistent with Priyadarsini et al. (2010) that 5-FU works by causing the G1/S arrest and induces apoptosis by inhibiting the biosynthesis process. MMDP containing quercetin suppresses the viability of HeLa cells in G2/M phase and induces apoptosis through mitochondrial pathways (Priyadarsini et al., 2010; Dun et al., 2015) . The presence of p21 interferes with CDK-cyclin interactions, thereby, inhibiting progression of the cell cycle (Wang et al., 2011) . A previous study showed that the MMDP containing quercetin has a potential anti-cancer agent (Endharti et al., 2016) . Plant parasites that contain compounds of bioactive treatment, repaired DNA damage by increasing percentage of p21 in HeLa cells (Parwati et al., 2015) . Moreover, combination therapy of 5-FU and 50 μg/ml MMDP shown a higher percentage of p21 than MMDP alone. Quercetin may increase the efficacy of 5-FU in human cancer cells (Xavier et al., 2011) .
Survivin is an apoptosis inhibitor protein that plays an important role in cancer cell division. Liu et al. (2015) suggested that survivin expression significantly increased in squamous cell carcinoma and adenocarcinoma. 5-FU decreased the expression of survivin but to a lesser extent than the combination therapy. MMDP has many benefits in the treatment of various diseases because it contains secondary metabolite compounds, such as quercetin. Quercetin may induce cancer cell death by mediating the expression of the apoptosis receptors and activity (Xavier et al., 2011; Fitrilia et al., 2015; Wang et al., 2016) and survivin expression (Han et al., 2016) .
5-FU rapidly enters into the cell via the uracil transport mechanism and is converted intra-cellularly into three active metabolites to inhibit thymidylate synthase could break DNA synthesis. DNA damage in cancer cells results in the induction of apoptosis through the activation of p53, modulation of the permeability of the mitochondrial membrane, and suppression of survivin expression (Srivastava et al., 2016) . Quercetin induced apoptosis by PI3K/Akt pathway (Kashafi et al., 2017) . The role of p21 in biological processes, such as DNA repair, remains controversial. In addition, p21 act as a proapoptosis if binding with NF-kβ and STAT so that it can inhibit survivin thus induce apoptosis. Akt is an antiapoptosis protein phosphorylating p21 occurs binding of p21 with PCNA could disruption induced checkpoint causes DNA repair or induced apoptosis (Karimian et al., 2016) . The mechanism of action of MMDP is similar to that of 5-FU, as it intercalates in cancer cell DNA, causing DNA damage and increased activation of the p53-induced apoptosis pathway; this activation suppresses the expression of survivin. In this study, combination therapy most significantly decreased the expression of survivin, however MMDP when administered singly effectively decreased the expression of survivin. This study supports the previous study that combination therapy with 5-FU and the other agent significantly decreases the expression of survivin (Liang et al., 2013) .
CONCLUSIONS
The study showed that the combination of 5-FU and MMDP able to increase the number of apoptosis cells, p21 expression and reduce survivin expression of HeLa cells. Our results highlight the new therapeutic concept which combines chemotherapy agents of 5-FU and MMDP in treating cervical cancer.
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